Wednesday, March 5, 2025
TechInvention Lifecare Pvt. Ltd. (TechInvention) is proud to announce a strategic collaboration with Belgium-based Quantoom Biosciences (Quantoom). The Memorandum of Understanding (MoU) was formally signed during the Belgian Economic Mission to India on Tuesday, March 4, 2025, in the presence of Her Royal Highness Princess Astrid of Belgium, industry leaders and key stakeholders from both nations.
With a One Health approach, this collaboration extends beyond human health to encompass animal and environmental health. The technology is designed for environmental sustainability, integrating modular, low-carbon-footprint mRNA systems that support global decarbonization efforts. It aligns with worldwide initiatives to enable access to next-generation RNA technologies, ensuring that low- and middle-income countries (LMICs) benefit from locally manufactured, cost-effective, and scalable solutions.
Syed Ahmed, Director & CEO, TechInvention, commented:
“We are excited to bring Quantoom’s cutting-edge mRNA technology to India, revolutionizing RNA drugs development and manufacturing. This partnership is a significant step toward strengthening India’s preparedness for future pandemics while ensuring broader access to RNA-based innovations across LMICs.”
This collaboration positions India as a hub for next-gen RNA-based vaccines, driving global partnerships for equitable healthcare.
RELATED PRESS ARTICLES